» Articles » PMID: 22332057

Probiotics and Other Key Determinants of Dietary Oxalate Absorption

Overview
Journal Adv Nutr
Publisher Elsevier
Date 2012 Feb 15
PMID 22332057
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Oxalate is a common component of many foods of plant origin, including nuts, fruits, vegetables, grains, and legumes, and is typically present as a salt of oxalic acid. Because virtually all absorbed oxalic acid is excreted in the urine and hyperoxaluria is known to be a considerable risk factor for urolithiasis, it is important to understand the factors that have the potential to alter the efficiency of oxalate absorption. Oxalate bioavailability, a term that has been used to refer to that portion of food-derived oxalate that is absorbed from the gastrointestinal tract (GIT), is estimated to range from 2 to 15% for different foods. Oxalate bioavailability appears to be decreased by concomitant food ingestion due to interactions between oxalate and coingested food components that likely result in less oxalic acid remaining in a soluble form. There is a lack of consensus in the literature as to whether efficiency of oxalate absorption is dependent on the proportion of total dietary oxalate that is in a soluble form. However, studies that directly compared foods of varying soluble oxalate contents have generally supported the proposition that the amount of soluble oxalate in food is an important determinant of oxalate bioavailability. Oxalate degradation by oxalate-degrading bacteria within the GIT is another key factor that could affect oxalate absorption and degree of oxaluria. Studies that have assessed the efficacy of oral ingestion of probiotics that provide bacteria with oxalate-degrading capacity have led to promising but generally mixed results, and this remains a fertile area for future studies.

Citing Articles

Oxalate regulates crystal-cell adhesion and macrophage metabolism via JPT2/PI3K/AKT signaling to promote the progression of kidney stones.

Song Q, Song C, Chen X, Xiong Y, He Z, Su X J Pharm Anal. 2024; 14(6):100956.

PMID: 39035219 PMC: 11259813. DOI: 10.1016/j.jpha.2024.02.010.


Oxalates: Dietary Oxalates and Kidney Inflammation: A Literature Review.

Karr T, Guptha L, Bell K, Thenell J Integr Med (Encinitas). 2024; 23(2):36-44.

PMID: 38911445 PMC: 11193404.


Detection of oxalyl-CoA decarboxylase (oxc) and formyl-CoA transferase (frc) genes in novel probiotic isolates capable of oxalate degradation in vitro.

Youssef H Folia Microbiol (Praha). 2024; 69(2):423-432.

PMID: 38217756 PMC: 11003902. DOI: 10.1007/s12223-024-01128-5.


Gut Microbiota's Oxalate-Degrading Activity and Its Implications on Cardiovascular Health in Patients with Kidney Failure: A Pilot Prospective Study.

Stepanova N, Tolstanova G, Aleksandrova I, Korol L, Dovbynchuk T, Driianska V Medicina (Kaunas). 2023; 59(12).

PMID: 38138292 PMC: 10744410. DOI: 10.3390/medicina59122189.


Nutrient synergy: definition, evidence, and future directions.

Townsend J, Kirby T, Sapp P, Gonzalez A, Marshall T, Esposito R Front Nutr. 2023; 10:1279925.

PMID: 37899823 PMC: 10600480. DOI: 10.3389/fnut.2023.1279925.


References
1.
Siva S, Barrack E, Reddy G, Thamilselvan V, Thamilselvan S, Menon M . A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease. BJU Int. 2008; 103(1):18-21. DOI: 10.1111/j.1464-410X.2008.08122.x. View

2.
Liebman M, Chai W . Effect of dietary calcium on urinary oxalate excretion after oxalate loads. Am J Clin Nutr. 1997; 65(5):1453-9. DOI: 10.1093/ajcn/65.5.1453. View

3.
Massey L . Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc. 2007; 107(7):1191-4. DOI: 10.1016/j.jada.2007.04.007. View

4.
Robertson W, Hughes H . Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula. Scanning Microsc. 1993; 7(1):391-401; discussion 401-2. View

5.
Kwak C, Kim H, Kim E, Choi M, Kim H . Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol. 2003; 44(4):475-81. DOI: 10.1016/s0302-2838(03)00318-x. View